Table:
begin	end	state
1	11	non-cytoplasmic
12	31	transmembrane
32	58	cytoplasmic
59	83	transmembrane
84	88	non-cytoplasmic
89	109	transmembrane
110	137	cytoplasmic
138	157	transmembrane
158	174	non-cytoplasmic
175	194	transmembrane
195	202	cytoplasmic
203	224	transmembrane
225	233	non-cytoplasmic
234	256	transmembrane
257	293	cytoplasmic
294	315	transmembrane
316	338	non-cytoplasmic
339	360	transmembrane
361	376	cytoplasmic
377	393	transmembrane
394	398	non-cytoplasmic
399	422	transmembrane
423	483	cytoplasmic

Input:
>Pf1N1B4_2024 FitnessBrowser__pseudo1_N1B4:Pf1N1B4_2024
MLEVINDFLSGKVLIVLIVGLGSYFTIRSRFVQFRHFFHMFAVFRDSLRSSAGQLSSFQA
LMLSLAGRVGAGNIAGVGIAVTLGGPGAVFWMWVTALVGMSSSFFECSLGQLYKRCDSEG
QFRGGPSFYIQHGLQKRWLGMIMAFLLLITFGFAFNGLQAHAVTHSLNNAFGLDTTYTGL
GLAVLLGLVFIGGIKRIAKVADLLVPVKTLVYIGVTIYVIVLQFDHVPGMLMTIVKSAFG
LDQAFGGLIGSAIVMGVKRGVFANEAGLGSAPNVAAVASVEHPVSQGVVQAFSVFLDTFV
ICTCTALLILLSGFYTPGFEGDGIALTQNSLAAVVGDWGRMFISVALALFVFTSILYNYY
LGENNLRFMVGENRKALIGYRALVLVLIFWGAIENLGTVFAFADITMTMLAFVNLIALFL
LFKVGMRILRDYDDQRAAGIKTPVFDSSKFPDLDLDLKAWPANPPAAAPTAAAEPQGVTA
AQR

Or try the official Phobius web server, which has a different display

Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server